1. Home
  2. THRD vs SVC Comparison

THRD vs SVC Comparison

Compare THRD & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • SVC
  • Stock Information
  • Founded
  • THRD 2019
  • SVC 1995
  • Country
  • THRD United States
  • SVC United States
  • Employees
  • THRD N/A
  • SVC N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • SVC Real Estate Investment Trusts
  • Sector
  • THRD Health Care
  • SVC Real Estate
  • Exchange
  • THRD Nasdaq
  • SVC Nasdaq
  • Market Cap
  • THRD 513.2M
  • SVC 461.6M
  • IPO Year
  • THRD 2022
  • SVC N/A
  • Fundamental
  • Price
  • THRD $10.84
  • SVC $2.48
  • Analyst Decision
  • THRD Strong Buy
  • SVC Buy
  • Analyst Count
  • THRD 3
  • SVC 2
  • Target Price
  • THRD $20.33
  • SVC $5.38
  • AVG Volume (30 Days)
  • THRD 259.3K
  • SVC 6.1M
  • Earning Date
  • THRD 11-07-2024
  • SVC 11-06-2024
  • Dividend Yield
  • THRD N/A
  • SVC 24.60%
  • EPS Growth
  • THRD N/A
  • SVC N/A
  • EPS
  • THRD N/A
  • SVC N/A
  • Revenue
  • THRD N/A
  • SVC $1,884,419,000.00
  • Revenue This Year
  • THRD N/A
  • SVC N/A
  • Revenue Next Year
  • THRD N/A
  • SVC N/A
  • P/E Ratio
  • THRD N/A
  • SVC N/A
  • Revenue Growth
  • THRD N/A
  • SVC N/A
  • 52 Week Low
  • THRD $8.08
  • SVC $2.29
  • 52 Week High
  • THRD $16.94
  • SVC $8.72
  • Technical
  • Relative Strength Index (RSI)
  • THRD 40.49
  • SVC 37.49
  • Support Level
  • THRD $10.53
  • SVC $2.29
  • Resistance Level
  • THRD $11.84
  • SVC $2.69
  • Average True Range (ATR)
  • THRD 0.86
  • SVC 0.18
  • MACD
  • THRD -0.07
  • SVC 0.00
  • Stochastic Oscillator
  • THRD 17.60
  • SVC 26.03

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.

Share on Social Networks: